Abstract:The pathophysiological function of the G-protein coupled melatonin MT1 and MT2 receptors has not yet been well-clarified. Recent advancements using selective MT1/ MT2 receptor ligands and MT1/MT2 receptor knockout mice have suggested that the activation of the MT1 receptors are mainly implicated in the regulation of rapid eye movement (REM) sleep, whereas the MT2 receptors selectively increase non-REM (NREM) sleep. Studies in mutant mice show that MT1 knockout mice have an increase in NREM sleep and a decrease in REM sleep, while MT2 knockout mice a decrease in NREM sleep. The localization of MT1 receptors is also distinct from MT2 receptors; for example, MT2 receptors are located in the reticular thalamus (NREM area), while the MT1 receptors in the Locus Coeruleus and lateral hypothalamus (REM areas). Altogether, these findings suggest that these two receptors not only have a very specialized function in sleep, but that they may also modulate opposing effects. These data also suggest that mixed MT1-MT2 receptors ligands are not clinically recommended given their opposite roles in physiological functions, confirmed by the modest effects of melatonin or MT1/MT2 non-selective agonists when used in both preclinical and clinical studies as hypnotic drugs. In sum, MT1 and MT2 receptors have specific roles in the modulation of sleep, and consequently, selective ligands with agonist, antagonist, or partial agonist properties could have therapeutic potential for sleep; while the MT2 agonists or partial agonists might be indicated for NREM-related sleep and/or anxiety disorders, the MT1 agonists or partial agonists might be so for REM-related sleep disorders. Furthermore, MT1 but not MT2 receptors seem involved in the regulation of the circadian rhythm. Future research will help further develop MT1 and/or MT2 receptors as targets for neuropsychopharmacology drug development.

Distribution of Melatonin Receptor in Human Fetal Brain

Distribution Of Mt1 Melatonin Receptor Immunoreactivity In The Human Hypothalamus And Pituitary Gland: Colocalization Of Mt1 With Vasopressin, Oxytocin, And Corticotropin-Releasing Hormone

The location, physiology, pathology of hippocampus Melatonin MT2 receptor and MT2-selective modulators

Co-Expression of Two Subtypes of Melatonin Receptor on Rat M1-Type Intrinsically Photosensitive Retinal Ganglion Cells

Protection of Melatonin in Experimental Models of Newborn Hypoxic‐ischemic Brain Injury Through MT1 Receptor

Identification of Melatonin Receptor in Human Bone Mesenchymals Stromal Cells and Its Significance

Localization of Melatonin Receptor Mel1a in Mudskipper (boleophthalmus Pectinirostris)

Structural Basis of the Ligand Binding and Signaling Mechanism of Melatonin Receptors

[Developmental Expression and Cellular Distribution of Metabotropic Glutamate Receptor 5 in the Frontal Cortex of Human Fetus].

Developmental Distribution Pattern of Metabotropic Glutamate Receptor 5 in Prenatal Human Hippocampus

Serotoninergic and Melatoninergic Systems Are Expressed in Mouse Embryonic Fibroblasts NIH3T3 Cells.

The Melatonin Receptor in the Bactrian Camel Pineal: Cloning Experiments and Distribution Studies

Differential Function of Melatonin MT1 and MT2 Receptors in REM and NREM Sleep

Function of Melatonin in Human Retina

Thirty‐seven years of MT1 and MT2 melatonin receptor localization in the brain: Past and future challenges

Melatonin receptor structure and signaling

The Developmental Expression of Metabotropic Glutamate Receptor 4 in Prenatal Human Frontal Lobe and Neurogenesis Regions

Dual sources of melatonin and evidence for different primary functions

Differential Distribution of GABAB1 and GABAB2 Receptor Mrnas in the Rat Brain

High-throughput Screening Assay for New Ligands at Human Melatonin Receptors

Interneuron origin and molecular diversity in the human fetal brain